Neuronal-microglial Liver X Receptor Β Activating Decrease Neuroinflammation and Chronic Stress-Induced Depression-Related Behavior in Mice.

Chunhui Li,Huanghui Wu,Ha Sen Ta Na,Lu Wang,Chuanqi Zhong,Bin Deng,Cong Liu,Han Bao,Hanfei Sang,Lichao Hou
DOI: https://doi.org/10.1016/j.brainres.2022.148112
IF: 3.61
2022-01-01
Brain Research
Abstract:Depression is accompanied by excessive neuroinflammation. Liver X receptor beta (LXR beta) has been reported as a newly emerging target that exerts systemic and organic inflammation modulation. However, the modulatory mechanism in alleviating neuroinflammation are far from being revealed. In the current study, depression-related behaviors in mice were induced by chronic unpredictable mild stress (CUMS) and corticosterone (CORT) drinking. Mice received either TO901317, PLX-5622 and intra-bilateral basolateral amygdale (BLA) injection of rAAV9-hSyn-hM3D(Gq)-eGFP to activate LXR beta, eliminate microglia and pharmacogenetic activate neurons in BLA, respectively, followed by behavioral tests. Microglial pro-inflammatory and pro-phagocytic activation, as well as nuclear factor-kappa B (NF-kappa B) signaling pathway, NLRP3 inflammasome activation and inter-leukin-1 beta (IL-1 beta) release in BLA were investigated. Moreover, pro-inflammatory activation of BV2 cells-induced by CORT with or without TO901317 was detected. Neuroinflammation indicated by IL-1 beta release was measured in a co-culture system of HT22-primary microglia with or without TO901317. Our results indicated that chronic stress induced depression-related behaviors, which were accompanied with microglial pro-inflammatory and pro-phagocytic activation, as well as NF-kappa B signaling pathway and NLRP3 inflammasome activation in BLA. Accordingly, pharmacological activation of LXR beta inhibited microglial pro-inflammatory and pro-phagocytic activation, as well as NF-kappa B signaling pathway and NLRP3 inflammasome activation, and IL-1 beta release both in vivo and in vitro. Finally, both elimination of microglia and pharmacogenetic activation of neurons in BLA protected mice from chronic stress-induced depression-related behavior. Collectively, pharmacological activa-tion of neuronal-microglial LXR beta alleviates depression-related behavior by modulating excessive neuro -inflammation via inhibiting NF-kappa B signaling pathway and NLRP3 inflammasome activation.
What problem does this paper attempt to address?